University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor

Thomas Vail, M.D.

Chair of Orthopedic Surgery

Dr. Thomas Parker Vail, chair of Orthopedic Surgery at UCSF, is a specialist in total joint replacement of the hip and knee and surgical treatment of arthritis and osteonecrosis. In his research, Vail focuses on innovative bone implant techniques, clinical outcomes to assess devices used in adult bone reconstruction and repair and replacement of cartilage.

As chair of Orthopedic Surgery, Vail oversees the department's clinical, research and education activities. He is working to develop a new musculoskeletal institute that will increase the department's clinical capacity and improve patients' experience, while integrating related research and training activities.

Conditions & Treatments

Clinics

Arthritis and Joint Replacement Center
1500 Owens St.
San Francisco, CA 94158
Phone: (415) 353–2808
Fax: (415) 353–2956

Hours: Monday to Friday, 8 a.m. – 5 p.m.

More about Thomas Vail

Additional Languages

Spanish

Education

Loyola University School of Medicine 1985

Residencies

Duke University, Orthopaedic Surgery 1991

Fellowships

Duke University, Reconstructive/Cosmetic Surgery 1992

Selected Research and Publications

  1. Bozic KJ, Lau E, Kurtz S, Ong K, Rubash H, Vail TP, Berry DJ. Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in medicare patients. J Bone Joint Surg Am. 2012 May 2; 94(9):794-800.
  2. Bozic KJ, Lau E, Kurtz S, Ong K, Rubash H, Vail TP, Berry DJ. Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in medicare patients. J Bone Joint Surg Am. 2012 May 2; 94(9):794-800.
  3. Worni M, Pietrobon R, Zammar GR, Shah J, Yoo B, Maldonato M, Takemoto S, Vail TP. System dynamics to model the unintended consequences of denying payment for venous thromboembolism after total knee arthroplasty. PLoS One. 2012; 7(4):e30578.
  4. Flink BJ, Rivelli SK, Cox EA, White WD, Falcone G, Vail TP, Young CC, Bolognesi MP, Krystal AD, Trzepacz PT, Moon RE, Kwatra MM. Obstructive sleep apnea and incidence of postoperative delirium after elective knee replacement in the nondemented elderly. Anesthesiology. 2012 Apr; 116(4):788-96.
  5. Lachiewicz PF, Bolognesi MP, Henderson RA, Soileau ES, Vail TP. Can tantalum cones provide fixation in complex revision knee arthroplasty? Clin Orthop Relat Res. 2012 Jan; 470(1):199-204.
  6. Cooke ME, Allon AA, Cheng T, Kuo AC, Kim HT, Vail TP, Marcucio RS, Schneider RA, Lotz JC, Alliston T. Structured three-dimensional co-culture of mesenchymal stem cells with chondrocytes promotes chondrogenic differentiation without hypertrophy. Osteoarthritis Cartilage. 2011 Oct; 19(10):1210-8.
  7. Giaconi JC, Link TM, Vail TP, Fisher Z, Hong R, Singh R, Steinbach LS. Morbidity of direct MR arthrography. AJR Am J Roentgenol. 2011 Apr; 196(4):868-74.
  8. Vail TP. Hip resurfacing. J Am Acad Orthop Surg. 2011 Apr; 19(4):236-44.
  9. Goldberg VM, Buckwalter J, Halpin M, Jiranek W, Mihalko W, Pinzur M, Rohan B, Vail T, Walker P, Windsor R, Wright T. Recommendations of the OARSI FDA Osteoarthritis Devices Working Group. Osteoarthritis Cartilage. 2011 May; 19(5):509-14.
  10. Vail TP. Commentary on an article by Joseph F. Styron, PhD, et al.: "Preoperative predictors of returning to work following primary total knee arthroplasty". J Bone Joint Surg Am. 2011 Jan 5; 93(1):e2.
  11. Bozic KJ, Maselli J, Pekow PS, Lindenauer PK, Vail TP, Auerbach AD. The influence of procedure volumes and standardization of care on quality and efficiency in total joint replacement surgery. J Bone Joint Surg Am. 2010 Nov 17; 92(16):2643-52.
  12. Queen RM, Watters TS, Abbey AN, Sabesan VJ, Vail TP, Bolognesi MP. Gait symmetry: a comparison of hip resurfacing and jumbo head total hip arthroplasty patients. J Arthroplasty. 2011 Aug; 26(5):680-5.
  13. Bozic KJ, Ong K, Lau E, Kurtz SM, Vail TP, Rubash HE, Berry DJ. Risk of complication and revision total hip arthroplasty among Medicare patients with different bearing surfaces. Clin Orthop Relat Res. 2010 Sep; 468(9):2357-62.
  14. Bozic KJ, Pui CM, Ludeman MJ, Vail TP, Silverstein MD. Do the potential benefits of metal-on-metal hip resurfacing justify the increased cost and risk of complications? Clin Orthop Relat Res. 2010 Sep; 468(9):2301-12.
  15. Nguyen L, Amin NH, Vail TP, Pietrobon R, Shah A. Editorial: a paucity of women among residents, faculty, and chairpersons in orthopaedic surgery. Clin Orthop Relat Res. 2010 Jul; 468(7):1746-8.
  16. Isaac GH, Siebel T, Oakeshott RD, McLennan-Smith R, Cobb AG, Schmalzried TP, Vail TP. Changes in whole blood metal ion levels following resurfacing: serial measurements in a multi-centre study. Hip Int. 2009 Oct-Dec; 19(4):330-7.
  17. Bozic KJ, Vail TP, Pekow PS, Maselli JH, Lindenauer PK, Auerbach AD. Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients? J Arthroplasty. 2010 Oct; 25(7):1053-60.
  18. Vail TP, Mont MA, McGrath MS, Zywiel MG, Beaulé PE, Capello WN. Hip resurfacing: patient and treatment options. J Bone Joint Surg Am. 2009 Aug; 91 Suppl 5:2-4.
  19. Vail TP, Mariani EM, Bourne MH, Berger RA, Meneghini RM. Approaches in primary total hip arthroplasty. J Bone Joint Surg Am. 2009 Aug; 91 Suppl 5:10-2.
  20. Bozic KJ, Kurtz S, Lau E, Ong K, Chiu V, Vail TP, Rubash HE, Berry DJ. The epidemiology of bearing surface usage in total hip arthroplasty in the United States. J Bone Joint Surg Am. 2009 Jul; 91(7):1614-20.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.